Tumor-Infiltrating Lymphocytes (TILs)

The spatial architecture of TILs is as critical as their density. Three distinct patterns are recognized:

• Intratumoral (iTILs): Lymphocytes directly infiltrating tumor cell nests and in direct contact with malignant cells
• Stromal (sTILs): Lymphocytes confined to the fibrous stroma between tumor islands without direct tumor cell contact
• Invasive margin: Lymphocytes concentrated at the tumor-host interface, forming an immune exclusion boundary

Spatial analysis using computational pathology reveals that iTILs are most strongly associated with favorable outcomes, while stromal-restricted patterns may indicate immune exclusion mechanisms.

Not all TILs are functionally equivalent. The immune phenotype is determined by the relative abundance of effector and suppressor populations:

• CD8+ Cytotoxic T Cells: The primary tumor-killing effectors; high density strongly correlates with improved survival
• CD4+ Helper T Cells: Orchestrate immune responses through cytokine signaling; Th1 polarization favors anti-tumor immunity
• FOXP3+ Regulatory T Cells (Tregs): Immunosuppressive cells that inhibit effector function; high Treg-to-CD8 ratios predict poor prognosis
• CD20+ B Cells: Contribute to tertiary lymphoid structure formation and antibody-mediated responses

Multiplex immunofluorescence enables simultaneous quantification of these subtypes within their native spatial context.

TIL assessment has evolved from subjective visual estimation to reproducible computational metrics:

• Semiquantitative Scoring: Pathologist-estimated percentage of stromal area occupied by TILs, per International TILs Working Group guidelines
• Automated Cell Detection: Deep learning models performing instance segmentation of individual lymphocytes on H&E-stained slides
• Density Metrics: TILs per square millimeter of tumor or stromal area, enabling standardized cross-study comparisons
• Spatial Statistics: Ripley's K-function and nearest-neighbor analyses quantifying clustering and dispersion patterns

Computational approaches reduce inter-observer variability and enable high-throughput analysis of large clinical cohorts.

TIL density is a stage-independent prognostic factor validated in multiple solid tumor types:

• Triple-Negative Breast Cancer: Each 10% increase in stromal TILs associates with 15-20% reduction in recurrence risk
• Melanoma: Presence of brisk TIL infiltrate is incorporated into AJCC staging considerations
• Colorectal Cancer: High TIL density, particularly CD8+ cells, outperforms TNM staging in predicting disease-specific survival
• Non-Small Cell Lung Cancer: TIL density predicts benefit from adjuvant chemotherapy and checkpoint blockade

These associations are strongest in immunogenic tumor types with high tumor mutational burden.

TIL assessment guides immune checkpoint inhibitor therapy decisions by identifying patients likely to respond:

• Pre-treatment TIL density correlates with response to anti-PD-1/PD-L1 therapies across multiple indications
• TIL expansion on treatment serves as an early pharmacodynamic biomarker of immune activation
• Clonal TIL expansion measured via T-cell receptor sequencing indicates tumor-specific immune responses
• Combination of TIL density with PD-L1 expression and tumor mutational burden improves patient stratification accuracy

TIL quantification provides complementary information to genomic biomarkers, capturing the functional state of anti-tumor immunity.

Tertiary Lymphoid Structures (TLS) represent organized aggregates of TILs that recapitulate lymph node architecture within the tumor microenvironment:

• Contain distinct B-cell follicles surrounded by T-cell zones, with specialized high endothelial venules
• Presence of mature, germinal center-containing TLS strongly predicts response to checkpoint inhibitors, independent of TIL density alone
• Serve as sites of local antigen presentation and B-cell affinity maturation, generating tumor-specific antibodies
• Computational detection using H&E-based deep learning enables scalable TLS quantification without immunohistochemistry

TLS represent a higher-order immune organization biomarker beyond simple cell counting.

A staining method using antibodies to detect specific protein antigens in tissue sections. For TIL assessment, CD3 (pan-T-cell) and CD8 (cytotoxic T-cell) IHC stains provide ground truth for lymphocyte identification.

• Enables precise cell-type classification beyond H&E morphology
• Used to validate deep learning TIL detection models
• PD-L1 IHC is a companion diagnostic for immunotherapy eligibility

An advanced imaging technique that simultaneously labels multiple protein markers on a single tissue section using distinct fluorophores. mIF enables spatial profiling of the tumor microenvironment by co-localizing TIL subsets with tumor cells and immune checkpoints.

• Captures functional phenotypes like exhausted CD8+PD-1+ T cells
• Generates spatial proximity maps between TILs and tumor cells
• Provides richer training data for deep learning models than single-plex IHC

The computational fusion of spatially-resolved molecular data with histology images. For TIL analysis, this involves overlaying gene expression patterns onto tissue architecture to understand the molecular programs of lymphocytes within specific tumor compartments.

• Links T-cell receptor clonality with spatial position
• Reveals immune exclusion vs. immune desert phenotypes
• Enables discovery of spatial biomarkers beyond simple TIL density

A biological characteristic that identifies patients likely to benefit from a specific targeted therapy. TIL density serves as a predictive biomarker for immune checkpoint inhibitor response across multiple cancer types, including melanoma, lung, and triple-negative breast cancer.

• High stromal TILs predict response to anti-PD-1/PD-L1 therapy
• Spatial distribution matters: intratumoral TILs may be more predictive than stromal
• Combined with Tumor Mutational Burden (TMB) for composite immunotherapy scores

A visualization technique that highlights image regions most influential to a deep learning model's decision. In TIL quantification models, attention heatmaps reveal whether the model is truly focusing on lymphocyte-rich stromal areas rather than spurious correlations like staining artifacts.

• Provides spatial interpretability for slide-level TIL scoring
• Validates that models attend to tumor-stroma interfaces where TILs concentrate
• Essential for regulatory approval of AI-based TIL assessment tools

A weakly-supervised learning paradigm where a model is trained using slide-level labels by aggregating predictions from unlabeled patches. For TIL analysis, MIL enables training on gigapixel whole-slide images where only overall TIL scores or clinical outcomes are available, without requiring pixel-level lymphocyte annotations.

• Eliminates need for exhaustive cell-level labeling
• Attention-based MIL identifies TIL-rich patches automatically
• Enables training on large retrospective cohorts with only outcome data